Le Lézard
Classified in: Health, Science and technology
Subjects: TRI, FVT

IDEAYA Biosciences Announces Participation at the 43rd Annual J.P. Morgan Healthcare Conference and 2025 Corporate Guidance


SOUTH SAN FRANCISCO, Calif., Jan. 12, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the 43rd Annual J.P. Morgan Healthcare Conference and provided 2025 corporate guidance and program updates.

43rd Annual J.P. Morgan Healthcare Conference
Monday, January 13th, 2025, at 5:15 PM PT (8:15 PM ET)

2025 Corporate Guidance to be Presented at the 43rd Annual J.P. Morgan Healthcare Conference:

IDEAYA's updated JPM 2025 corporate presentation reflecting its 2025 corporate guidance is available on its website under the Investor Relations section: https://ir.ideayabio.com/.

A live audio webcast of the presentation and Q&A session will be available under the "Investors/Events" section of the IDEAYA website at https://ir.ideayabio.com/events and/or through the conference host. A replay of the webcast will be accessible for 30 days following the live event.

About IDEAYA Biosciences

IDEAYA is a precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.  IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with drug discovery to select patient populations most likely to benefit from its targeted therapies.  IDEAYA is applying its early research and drug discovery capabilities to synthetic lethality ? which represents an emerging class of precision medicine targets. 

Forward-Looking Statements

This press release contains forward-looking statements, including, but not limited to, statements related to (i) participation in and/or presentation at certain investor relations events and (ii) 2025 corporate guidance regarding the extent to which IDEAYA's existing cash, cash equivalents, and marketable securities will fund its planned operations and (iii) program updates regarding the potential timing of various activities. IDEAYA undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of IDEAYA in general, see IDEAYA's current and future filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K filed on February 20, 2024.

Investor and Media Contact
IDEAYA Biosciences
Andres Ruiz Briseno
Senior Vice President, Head of Finance and Investor Relations
[email protected] 

SOURCE IDEAYA Biosciences, Inc.


These press releases may also interest you

at 16:41
Chef&Nutri was born out of the need to encourage healthier living. Focused on the ingestion of nutritionally complete, sustainable and functional foods, based in Bahia, the company is expanding its operations to the Southeast, Midwest and South, in...

at 13:27
Joint Announcement of the Teslin Tlingit Council, Government of Yukon, and Government of Canada Today, the Teslin Tlingit Council, the Honourable Gary Anandasangaree, Minister of Crown-Indigenous Relations and Northern Affairs, and the Government of...

at 08:00
On Saturday February 8th at 12 noon, the Grey Bruce, Brampton Caledon and Greater Toronto health coalitions, local chapters of the Ontario Health Coalition, will gather outside Minister of Health Sylvia Jones' constituency office to oppose and expose...

at 03:01
From February 6 to 9, 2025, the HICC Pet brand is showcasing its groundbreaking grooming and healthcare products at the Hong Kong Convention and Exhibition Centre during the Pet Show Hong Kong 2025. Known as a leader in pet healthcare, HICC Pet...

at 02:36
Report on how AI is driving market transformation - The global senior living market  size is estimated to grow by USD 130.9 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of  5.8%  during the forecast...

7 fév 2025
Report with the AI impact on market trends - The global healthcare services market size is estimated to grow by USD 6.26 trillion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 8.73% during the forecast period....



News published on and distributed by: